Zura Bio Ltd
ZURA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001855644
No open-market purchases or sales by Zura Bio Ltd insiders were filed in the last 90 days; 95 institutions reported holding it in 13F filings for Q2 2026, worth $428.9M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Zura Bio Ltd as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 45
- +1 vs. Q4 2023
- Shares held
- 14.9M
- −281.3K (−1.9%) vs. Q4 2023
- Total value
- $37.6M
- −$33.1M (−46.8%) vs. Q4 2023
- New holders
- 5
- 14 more added
- Sold out
- 4
- 19 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ZURA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 95 | $428.9M |
| Q1 2026 | 94 | $391.8M |
| Q4 2025 | 75 | $235.1M |
| Q3 2025 | 69 | $179.2M |
| Q2 2025 | 65 | $37.1M |
| Q1 2025 | 74 | $59.0M |
| Q4 2024 | 87 | $107.2M |
| Q3 2024 | 78 | $151.1M |
| Q2 2024 | 57 | $114.9M |
| Q1 2024 | 45 | $37.6M |
| Q4 2023 | 44 | $70.7M |
| Q3 2023 | 41 | $93.3M |
| Q2 2023 | 38 | $105.0M |
| Q1 2023 | 3 | $24.7K |
| Q4 2022 | 35 | $87.4M |
| Q3 2022 | 33 | $84.2M |
| Q2 2022 | 36 | $77.7M |
| Q1 2022 | 34 | $58.1M |
| Q4 2021 | 25 | $48.5M |
| Q3 2021 | 17 | $31.6M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Zura Bio Ltd; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Suvretta Capital Management, LLC | 2,850,000 | $7.32M | 0.31% | 00.0% | Unchanged |
| Great Point Partners LLC | 2,757,740 | $7.09M | 1.10% | −537,260−16.3% | Reduced |
| Deep Track Capital, LP | 2,523,000 | $6.48M | 0.19% | 00.0% | Unchanged |
| Armistice Capital, LLC | 1,648,000 | $4.24M | 0.11% | −176,000−9.6% | Reduced |
| BlackRock Inc. | 1,094,617 | $2.81M | 0.00% | −14,327−1.3% | Reduced |
| Citadel Advisors LLC | 681,420 | $1.75M | 0.00% | −11,374−1.6% | Reduced |
| Vanguard Group Inc | 575,092 | $1.48M | 0.00% | +20,047+3.6% | Added |
| Geode Capital Management, LLC | 487,125 | $1.25M | 0.00% | +437+0.1% | Added |
| Affinity Asset Advisors, LLC | 450,009 | $1.16M | 0.19% | +450,009 | New |
| Silverarc Capital Management, LLC | 328,504 | $844.3K | 0.24% | −134,493−29.0% | Reduced |
| State Street Corp | 214,748 | $551.9K | 0.00% | +23,738+12.4% | Added |
| Charles Schwab Investment Management Inc | 183,242 | $470.9K | 0.00% | +4,230+2.4% | Added |
| Northern Trust Corp | 172,717 | $443.9K | 0.00% | +2,540+1.5% | Added |
| Raymond James & Associates | 111,347 | $286.2K | 0.00% | +33,452+42.9% | Added |
| Atom Investors LP | 94,982 | $244.1K | 0.03% | +48,714+105.3% | Added |
| Jane Street Group, LLC | 53,117 | $136.5K | 0.00% | +53,117 | New |
| Bank of New York Mellon Corp | 40,697 | $104.6K | 0.00% | −710−1.7% | Reduced |
| Forefront Analytics, LLC | 34,038 | $87.5K | 0.04% | +12,809+60.3% | Added |
| Hudson Bay Capital Management LP | 38,999 | $85.6K | 0.00% | −39,000−50.0% | Reduced |
| Meteora Capital, LLC | 28,702 | $73.8K | 0.01% | 00.0% | Unchanged |
| Alliancebernstein L.P. | 25,090 | $64.5K | 0.00% | 00.0% | Unchanged |
| Nuveen Asset Management, LLC | 23,657 | $60.8K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 22,160 | $57.0K | 0.00% | −36,324−62.1% | Reduced |
| Invesco Ltd. | 21,456 | $55.1K | 0.00% | −98,984−82.2% | Reduced |
| Calamos Advisors LLC | 200,000 | $54.0K | 0.00% | +200,000 | New |
| Occudo Quantitative Strategies LP | 19,042 | $48.9K | 0.01% | −1,744−8.4% | Reduced |
| UBS Group AG | 17,232 | $44.3K | 0.00% | +17,232 | New |
| Rhumbline Advisers | 15,523 | $39.9K | 0.00% | +556+3.7% | Added |
| Bank of America Corp | 14,354 | $36.9K | 0.00% | −10,756−42.8% | Reduced |
| Barclays PLC | 12,336 | $31.7K | 0.00% | −11,275−47.8% | Reduced |
| Renaissance Technologies LLC | 11,500 | $30.0K | 0.00% | −300−2.5% | Reduced |
| Eisler Capital (US) LLC | 100,000 | $27.0K | 0.01% | 00.0% | Unchanged |
| New York State Common Retirement Fund | 8,547 | $22.0K | 0.00% | +49+0.6% | Added |
| American International Group, Inc. | 8,396 | $21.6K | 0.00% | −72−0.9% | Reduced |
| JPMorgan Chase & Co | 7,284 | $18.7K | 0.00% | −4,946−40.4% | Reduced |
| Wells Fargo & Company | 6,102 | $15.7K | 0.00% | +773+14.5% | Added |
| Tower Research Capital LLC (TRC) | 4,307 | $11.1K | 0.00% | +1,584+58.2% | Added |
| Citigroup Inc | 3,195 | $8.21K | 0.00% | +683+27.2% | Added |
| FMR LLC | 2,962 | $7.61K | 0.00% | +1,769+148.3% | Added |
| California State Teachers Retirement System | 1,934 | $4.97K | 0.00% | −870−31.0% | Reduced |
| STRS Ohio | 1,500 | $4.00K | 0.00% | −100−6.3% | Reduced |
| Ameritas Investment Partners, Inc. | 626 | $1.61K | 0.00% | 00.0% | Unchanged |
| Amalgamated Bank | 256 | $1.00K | 0.00% | −406−61.3% | Reduced |
| Impact Partnership Wealth, LLC | 6 | $15 | 0.00% | −194−97.0% | Reduced |
| Capital Advisors, Ltd. LLC | 33 | $0 | 0.00% | +33 | New |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −32,486−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −19,458−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −12,037−100.0% | Sold out |
| Amundi | 0 | $0 | 0.00% | −9,929−100.0% | Sold out |